AIDS Treatment News logo      

September 30, 2009

Overview of ARV studies at IAS [July 19-22, 2009, in Cape Town, South Africa]

"The conference included a broad range of important studies that could inform use of currently approved drugs, and first results of a new integrase inhibitor.

"First results of new integrase compound: GSK1349572


"Raltegravir in treatment-naive patients


"Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study


"Darunavir/r monotherapy studies


Maraviroc results similar to efavirenz when analysed using more sensitive tropism test"

Read more in i-base, September/October 2009.